Lawson Macartney serves as Executive at Viking Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Lawson Macartney has executed 9 insider transactions totaling $1.4M, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 2, 2026 involved receiving (via award) 20,400 shares valued at $0.
Lawson Macartney currently holds 20,400 shares of Viking Therapeutics, Inc. (VKTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Lawson Macartney has been a net seller of VKTX stock. They have purchased $250.4K and sold $1.2M worth of shares.
Lawson Macartney's most recent insider trade was on Jan 2, 2026, when they sold 20,400 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| May 16, 2023 | VKTX | $19.0K | Option Exercise | 16,000 | $1.19 | Discretionary |
| May 16, 2023 | VKTX | $384.0K | Sale | 16,000 | $24.00 | Discretionary |
| Apr 24, 2023 | VKTX | $352.0K | Sale | 16,000 | $22.00 | Discretionary |
| Apr 24, 2023 | VKTX | $53.3K | Option Exercise | 16,000 | $3.33 | Discretionary |
| Apr 17, 2023 | VKTX | $415.7K | Sale | 20,786 | $20.00 | Discretionary |
| Apr 17, 2023 | VKTX | $166.3K | Option Exercise | 20,786 | $8.00 | Discretionary |
| May 29, 2018 | VKTX | $250.4K | Purchase | 47,965 | $5.22 | Discretionary |